Lataa...

Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis

Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD), and as the disease progresses SHPT is associated with systemic consequences, termed CKD-mineral and bone disorder. Currently, cinacalcet is indicated for the treatment of SHPT; however, cinacalcet is assoc...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Yokoyama, Keitaro, Shimazaki, Ryutaro, Fukagawa, Masafumi, Akizawa, Tadao
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478860/
https://ncbi.nlm.nih.gov/pubmed/31015494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-42017-z
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!